VAISHALI PHARMA Fact Sheet, VAISHALI PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA Fact Sheet    (VAIS)


Register Now: Turn This Market Crash to Your Advantage (Today 5pm)


Here is the latest financial fact sheet of VAISHALI PHARMA . For more details, see the VAISHALI PHARMA quarterly results and VAISHALI PHARMA share price and chart.

VAISHALI PHARMA Price History

Price Rs 36.6
Mkt Cap Rs m 385
Vol '000 57.4
P/E X 16.3
P/CF X 26.2
EPS (TTM) Rs 2.2
1 Day % -2.5
No. of shares m 10.55
1 Week % -3.9
1 Month % 10.4
1 Year % -31.5
52 week H/L Rs 54.0/29.0
As on Jan 24, 2022 1:24:43 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

VAISHALI PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
VAISHALI PHARMA  EQUITY SHARE DATA
High RsNA726049NA 
Low RsNA484024NA 
Sales per share (Unadj.) Rs213.2102.8113.957.051.0 
Earnings per share (Unadj.) Rs2.41.21.101.0 
Diluted earnings per shareRs0.70.80.70.01.0 
Cash flow per share (Unadj.) Rs3.31.61.50.41.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %NM000NM 
Book value per share (Unadj.) Rs13.331.332.520.321.3 
Adj. book value per shareRs3.819.520.320.321.3 
Shares outstanding (eoy) m3.006.596.5910.5510.55 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x00.60.40.60 
Avg P/E ratio x049.446.11,170.50 
P/CF ratio (eoy) x037.533.581.30 
Price / Book Value ratio x01.91.51.80 
Dividend payout %00000 
Avg Mkt Cap Rs m03943293830 
No. of employees `000NANANANANA 
Total wages/salary Rs m1620211312 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
VAISHALI PHARMA  INCOME DATA
Net Sales Rs m640678751601538 
Other income Rs m917202218 
Total revenues Rs m649694771623556 
Gross profit Rs m352821926 
Depreciation Rs m33344 
Interest Rs m3129272626 
Profit before tax Rs m101311114 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m35404 
Profit after tax Rs m787010 
Gross profit margin %5.44.12.81.54.9 
Effective tax rate %31.240.737.058.625.5 
Net profit margin %1.11.21.00.11.9 
VAISHALI PHARMA  BALANCE SHEET DATA
Current assets Rs m399591630612813 
Current liabilities Rs m373408425404593 
Net working cap to sales %4.026.927.334.641.0 
Current ratio x1.11.41.51.51.4 
Inventory Days Days2020212023 
Debtors Days Days213,802,959240,132,513240,236,955285,684,199452,945,946 
Net fixed assets Rs m4851574947 
Share capital Rs m306666105105 
"Free" reserves Rs m10140148108119 
Net worth Rs m40206214214224 
Long term debt Rs m3426484140 
Total assets Rs m447641686661860 
Interest coverage x1.31.51.41.01.5 
Debt to equity ratio x0.80.10.20.20.2 
Sales to assets ratio x1.41.11.10.90.6 
Return on assets %8.55.74.93.94.3 
Return on equity %17.93.93.30.24.7 
Return on capital %56.218.114.510.415.2 
Exports to sales %26.823.318.721.716.7 
Imports to sales %0.70000 
Exports (fob) Rs m17115814013090 
Imports (cif) Rs m40000 
Fx inflow Rs m17115814013090 
Fx outflow Rs m72220 
Net fx Rs m16515613812890 
VAISHALI PHARMA  CASH FLOW
From Operations Rs m 5 -95 43 32 20 
From Investments Rs m 7 11 -3 0 -1 
From Financial Activity Rs m -12 85 -40 -31 -18 
Net Cashflow Rs m 0 1 0 1 1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 56.3%
Institution 0.0%
Non-Institution 43.7%
Total 100.0%
Free Float 43.7%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off 706 To 709 7th Floor Aravali Busines Center, R. C. Patel Road Off Sodawala Lane, Borivali (West), Mumbai - 400092
E-mail investor@vaishalipharma.com Web www.vaishalipharma.com
Tel 022 42171819 Fax 022 28928833
Sector PHARMACEUTICALS Group Private sector
Tr Agent Bigshare Services Pvt Ltd, Bharat Tin Works Building, 1st floor Opp. Vasant Oasis, Andheri (E)
YEAR OF INC: 2008 NSE CODE: 563147895 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ADANI PORTS & SEZ    MPS    AVANTI FEEDS    KAVERI SEED    CONTROL PRINT    

Compare VAISHALI PHARMA With:   ADANI PORTS & SEZ    MPS    AVANTI FEEDS    KAVERI SEED    CONTROL PRINT    




Today's Market

Sensex Tanks 650 Points Tracking Weak Global Cues, Nifty Below 17,450; Metal & IT Stocks Bleed(10:30 am)

Asian stock markets are lower today on expectations that the Fed will soon start draining the massive liquidity that has fueled the huge gains in growth stocks in recent years.

Views on news

JLR, Corus, Tetley - Was Ratan Tata's Go Global Strategy Right Afterall? (Views On News)

Jan 20, 2022

Ratan Tata took the lead in global acquisitions and changed the mindset of India's business leaders. Was he successful after all?

Top 4 Oxygen Stocks to Add to Your Watchlist (Views On News)

Jan 12, 2022

Amid a surge in Covid cases, states have been asked to keep adequate stock of medical oxygen for at least 48 hours.

Omicron: Sectors to Buy and Avoid in 2022 (Views On News)

Jan 11, 2022

We take a look at how stocks of 6 major sectors were impacted, the last time lockdowns were imposed and what we can learn from it.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Top 5 Bluechip Growth Stocks to Add to Your Watchlist (Views On News)

Jan 10, 2022

In a volatile market, these 'bluest of the bluechips' can bring stability to your portfolio.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VAISHALI PHARMA

  • Track your investment in VAISHALI PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VAISHALI PHARMA

VAISHALI PHARMA - ADCOCK INGRAM COMPARISON

COMPARE VAISHALI PHARMA WITH

MARKET STATS